Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ZNTL stock hub

Zentalis Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ZNTLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

312.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ZNTL

In the news

Latest news · ZNTL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-49.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-27.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ZNTL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001725160
Company name	Zentalis Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	98943L107
Employees	106
Employees Change	-60%
Employees Change Percent	-36.14
Enterprise value	$106.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-04-03
Isin	US98943L1070
Last refreshed	2026-05-10
Market cap	$312.8M
Market cap category	Small-Cap
Price	$4.41
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	ZNTL
Website	https://zentalis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-43.82%
FCF yield	-40.04%
P/B ratio	1.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-137.1M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Profit Per Employee	$-1.3M
ROA	-24.48
Roa5y	-27.42
ROCE	-55.81
ROE	-49.53
Roe5y	-53.29
ROIC	-27.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	258.85%
Cagr3y	-41.72%
Cagr5y	-40.51%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$289M
Cash	$245.9M
Current Assets	$253.2M
Current Liabilities	$36.6M
Debt	$39.6M
Debt Equity	$0.18
Equity	$216.2M
Liabilities	$72.8M
Long Term Assets	$35.8M
Long Term Liabilities	$36.2M
Net Cash	$206.3M
Net Cash By Market Cap	$65.96
Net Cash Growth	-37.18%
Net Debt Equity	$-0.95
Tangible Book Value	$216.2M
Tangible Book Value Per Share	$3.13
WACC	13.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.93
Net Working Capital	$-25.4M
Quick ratio	6.73
Working Capital	$216.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.11%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	258.54%
200-day SMA	2.18
3Y total return	-80.22%
50-day SMA	3.39
50-day SMA vs 200-day SMA	50over200
5Y total return	-92.55%
All Time High	87.19
All Time High Change	-94.94%
All Time High Date	2021-11-04
All Time Low	1.01
All Time Low Change	336.63%
All Time Low Date	2025-04-09
ATR	0.41
Beta	2
Beta1y	4.75
Beta2y	3.39
Ch YTD	226.7
High	4.44
High52	6.95
High52 Date	2026-04-10
High52ch	-36.55%
Low	4.2
Low52	1.13
Low52 Date	2025-07-01
Low52ch	290.27%
Ma50ch	30.24%
Price vs 200-day SMA	102.2%
RSI	58.31
RSI Monthly	44.78
RSI Weekly	59.66
Sharpe ratio	1.53x
Sortino ratio	3.36
Total Return	-1.11%
Tr YTD	226.7
Tr1m	65.17%
Tr1w	7.82%
Tr3m	84.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$7.5
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.52
Operating Income	$-140.9M
Price target	$6.6
Price Target Change	$49.66
Price Target Change Top	$70.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,666,310%
Float Percent	68.61%
Shares Insiders	1.59%
Shares Institutions	52.49%
Shares Out	70,931,016
Shares Qo Q	-0.66%
Shares Yo Y	1.11%
Short Float	10.69%
Short Ratio	1.39
Short Shares	7.34

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-146M
Average Volume	1,590,327.15x
Bv Per Share	3.13
Ch1m	65.17
Ch1w	7.82
Ch1y	258.5
Ch3m	84.52
Ch3y	-80.22
Ch5y	-92.55
Ch6m	244.5
Change	4.26%
Change From Open	3.52
Close	4.23
Days Gap	0.71
Depreciation Amortization	739,000
Dollar Volume	3,393,653.8
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-140.9M
EBITDA	$-140.1M
EPS	$-1.91
F Score	1
FCF	$-125.2M
FCF EV Yield	-117.61x
FCF Per Share	$-1.77
Financing CF	-4,282,000
Fiscal Year End	December
Founded	2,014
Income Tax	$442,000
Investing CF	131,623,000
Ipr	-75.5
Iprfo	-82.5
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-26
Ma150	2.39
Ma150ch	84.44%
Ma20	4.34
Ma20ch	1.64%
Net CF	2,094,000
Next Earnings Date	2026-05-22
Open	4.26
Optionable	Yes
Position In Range	88.11
Post Close	4.41
Postmarket Change Percent	-2.72
Postmarket Price	$4.29
Ppne	29,041,000
Price Date	2026-05-08
Ptbv Ratio	1.45
Relative Volume	0.48x
Share Based Comp	20,722,000
Tr6m	244.53%
Us State	California
Volume	769,536

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ZNTL pay a dividend?

Capital-return profile for this ticker.

Performance

ZNTL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ZNTL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+52.5%

Float: +68.6% of shares outstanding

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ZNTL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.3

Neutral momentum band

Price vs 200-day MA

+102.2%

50/200-day relationship not available

Beta (5Y)

2.00

More volatile than the market

Sharpe ratio

1.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ZNTL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ZNTL stock rating?

Zentalis Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ZNTL analysis?

The full report lives at /stocks/ZNTL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ZNTL?

The latest report frames ZNTL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ZNTL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.